HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Maybelline Defeats Class-Certification Bid In SuperStay Claims Case

This article was originally published in The Rose Sheet

Executive Summary

A survey of Maybelline SuperStay 24HR cosmetics users, offered by an expert witness, helped persuade a federal court in California to deny class-action certification in a case targeting the brand’s advertising and labeling claims. Because evidence demonstrates that most purchasers were satisfied with the lipstick and makeup products, were not misled or bought them for reasons other than durability, the proposed class of “injured” consumers was overly broad and unascertainable, according to the court.

You may also be interested in...



Beauty Firms: Take Lessons From Food Industry In Class-Action Defense

Personal-care firms targeted with class actions over “natural” claims and other marketing can look to recent cases in the food sector for defense strategies that have proven effective, say two food and drug law attorneys. While suits targeting product claims are decidedly expensive and PR challenges, recent developments suggest that firms can strategize and invest to escape paying class damages.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

L’Oreal Joins J&J And Major Retailers Defending Benzene Class Actions In Federal Courts

Benzoyl peroxide-based acne drug products and their alleged proclivity to become contaminated with carcinogenic benzene are at the center of putative class actions filing against L’Oreal in federal courts around the US.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019054

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel